| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 04/13/2000 | CA2344765A1 Novel peptides |
| 04/13/2000 | CA2344551A1 P-conotoxin peptide |
| 04/12/2000 | EP0992513A2 Isolated metallopeptide: compositions and synthetic methods |
| 04/12/2000 | EP0991665A1 Peptides and compounds that bind to the il-5 receptor |
| 04/12/2000 | EP0991660A1 Deuterated cyclosporine analogs and their use as immunomodulating agents |
| 04/12/2000 | EP0991659A1 Peptides and compounds that bind to the il-5 receptor |
| 04/12/2000 | EP0991658A1 Dolastatin 15 derivatives |
| 04/12/2000 | EP0991417A1 Complex formation between dsdna and oligomer of heterocycles |
| 04/12/2000 | EP0642666B1 Hepatitis c assay |
| 04/11/2000 | US6048840 Hypoglycaemic peptides |
| 04/11/2000 | US6048705 Sandwich immunoassays for collagen type I degradation products |
| 04/11/2000 | US6048685 In vitro diagnostic assay employing HIV-2 antigens for the detection of HIV-2 specific antibodies |
| 04/11/2000 | US6048527 Non-autoreactive; n-propionylated neisseria serogroup b capsular polysaccharide-protein conjugates |
| 04/11/2000 | CA2174314C Electrophilic peptide analogs as inhibitors of trypsin-like enzymes |
| 04/11/2000 | CA1340958C Synthetic peptides representing a t-cell epitope as a carrier molecule for conjugate vaccines |
| 04/11/2000 | CA1340956C Synthetic peptides representing a t-cell epitope as a carrier molecule for conjugate vaccines |
| 04/06/2000 | WO2000018921A2 Synthetic peptides having fgf receptor affinity |
| 04/06/2000 | WO2000018895A1 Short peptides which selectively modulate the activity of protein kinases |
| 04/06/2000 | WO2000018801A2 Ncam binding compounds |
| 04/06/2000 | WO2000018795A2 Compositions and methods for wt1 specific immunotherapy |
| 04/06/2000 | WO2000018793A1 Peptide derivative |
| 04/06/2000 | WO2000018791A1 Ligand presenting assembly (lpa), method of preparation and uses thereof |
| 04/06/2000 | WO2000018790A1 Synthesis of cyclic peptides |
| 04/06/2000 | WO2000018789A1 Auxiliary for amide bond formation |
| 04/06/2000 | WO2000018440A1 Somatostatin receptor radioligand with increased uptake |
| 04/06/2000 | WO2000018424A1 Use of substances with oxytocin activity in order to create cell regeneration |
| 04/06/2000 | WO2000018351A2 Aglyco products and methods of use |
| 04/06/2000 | WO1999062933A3 Rationally designed peptides, production and use thereof |
| 04/06/2000 | WO1999058162A3 Pharmaceuticals for the imaging of angiogenic disorders |
| 04/06/2000 | WO1999051625A3 Peptides causing formation of compact structures |
| 04/06/2000 | WO1999046284A3 Molecules that home to various selected organs or tissues |
| 04/06/2000 | WO1999036568A3 Method for identifying t-cell stimulating protein fragments |
| 04/06/2000 | CA2345407A1 Synthesis of cyclic peptides |
| 04/06/2000 | CA2345067A1 Auxiliary for amide bond formation |
| 04/06/2000 | CA2343975A1 Ncam binding compounds |
| 04/06/2000 | CA2343934A1 Short peptides which selectively modulate the activity of protein kinases |
| 04/06/2000 | CA2343924A1 Peptide derivative |
| 04/06/2000 | CA2341763A1 Antigenic peptides of aglyco 10b and antibodies thereto |
| 04/06/2000 | CA2341489A1 Somatostatin receptor radioligand with increased uptake |
| 04/06/2000 | CA2285151A1 Novel heparin binding peptides |
| 04/05/2000 | EP0990156A1 Cyclic peptide libraries and methods of use thereof to identify binding motifs |
| 04/05/2000 | EP0990034A1 Anti-gpiib/iiia recombinant antibodies |
| 04/05/2000 | EP0989996A2 Human preprotachykinin b |
| 04/05/2000 | EP0989858A1 Cd28/ctla-4 inhibiting peptidomimetics, pharmaceutical compositions thereof, and method of using same |
| 04/05/2000 | EP0794959B1 Amino acids for making betides and methods of screening and making betide libraries |
| 04/05/2000 | EP0741869B1 Specific binding substances for antibodies and their use for immunoassays or vaccines |
| 04/05/2000 | EP0740791A4 Systematic modular production of aminimide- and oxazolone-based molecules having selected properties |
| 04/05/2000 | EP0716661B1 Pseudo- and non-peptide bradykinin receptor antagonists |
| 04/05/2000 | CN1249433A NANBV diagnostics and vaccine |
| 04/05/2000 | CN1249310A Cationic polypeptide process for expressing antimicrobe in plant |
| 04/05/2000 | CN1051091C Method for detecting antibodies to hepatitis C virus |
| 04/04/2000 | US6046307 Modulation of mammalian telomerase by peptide nucleic acids |
| 04/04/2000 | US6046167 For controlling biological activities such as cell proliferation, nutrient transport, lipolysis, and intestinal water and electrolyte secretion |
| 04/04/2000 | US6046047 Genetic construct encoding a chimeric protein with a domain which binds and crosslinks a synthetic, membrane permeable, non-peptide ligand and domain to cause cellular localization of complex; for gene therapy and inducible gene expression |
| 04/04/2000 | US6045799 Inducing infertility in a mammal by administering a recombinant chimeric protein in a diluent, adjuvant or carrier |
| 04/04/2000 | CA2127331C Motilin-like polypeptides that inhibit gastrointestinal motor activity |
| 03/30/2000 | WO2000017348A1 G protein-coupled receptor agonists or antagonists |
| 03/30/2000 | WO2000017226A1 Synthetic peptides, conjugation reagents and methods |
| 03/30/2000 | WO2000009711A8 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1) |
| 03/30/2000 | WO2000000214A3 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
| 03/30/2000 | WO1999057281A3 Peptide antibiotics which inhibit the growth of pneumococci, abc transporter and two-component signal transduction system proteins from streptococcus pneumoniae, and methods using the same |
| 03/30/2000 | CA2689373A1 G protein-coupled receptor antagonists |
| 03/29/2000 | EP0989136A1 Peptides having cyclic structures and exerting p53 protein activty-restoring effect on p53 protein mutants |
| 03/29/2000 | EP0988394A1 Compositions for the detection of enzyme activity in biological samples and methods of use thereof |
| 03/29/2000 | EP0988377A1 Zinc finger protein derivatives and methods therefor |
| 03/29/2000 | EP0988314A1 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
| 03/29/2000 | EP0988048A1 Ligand/lytic peptide compositions and methods of use |
| 03/29/2000 | EP0552284B1 Isolated metallopolypeptide: compositions and synthetic methods |
| 03/28/2000 | US6043341 Cyclic peptide antifungal agents |
| 03/28/2000 | US6043220 Threonine-containing protegrins |
| 03/28/2000 | US6043212 Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor |
| 03/28/2000 | US6043082 Two genetic constructs encoding chimeric proteins, each with ligand binding domain to complex with the other protein; one protein also with domain which induces biological process, the other having intracelluar targeting domain; gene therapy |
| 03/28/2000 | CA2164712C Trifunctional antithrombin and antiplatelet peptides |
| 03/28/2000 | CA2008735C Human epidermal growth factor (egf) receptor sequences and egf competitive monoclonal antibodies |
| 03/28/2000 | CA2004885C Anticoagulant peptides |
| 03/23/2000 | WO2000015655A1 Process for producing peptides from biological fluids and peptides obtainable by said process |
| 03/23/2000 | WO2000015214A1 Fc RECEPTOR MODULATORS AND USES THEREOF |
| 03/23/2000 | WO2000015188A1 Cosmetic or dermopharmaceutical use of peptides for healing, hydrating and improving skin appearance during natural or induced ageing (heliodermia, pollution) |
| 03/23/2000 | WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS |
| 03/23/2000 | DE19816732A1 Diagnostik und Therapie von Erkrankungen im Zusammenhang mit HHV-8-Infektionen Diagnosis and treatment of diseases associated with HHV-8 infection |
| 03/23/2000 | CA2342395A1 Process for producing peptides from biological fluids and peptides obtainable by said process |
| 03/22/2000 | EP0987275A2 Molecules that home to a selected organ or tissue in vivo and methods of identifying same |
| 03/22/2000 | EP0986754A1 Synthetic antibiotics |
| 03/22/2000 | EP0986636A1 Method for generating activated t-cells and antigen-pulsed antigen-presenting cells |
| 03/22/2000 | EP0986577A2 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 03/22/2000 | EP0986395A1 Peptide parathyroid hormone analogs |
| 03/22/2000 | EP0792373B1 A scintillation proximity assay for n-acetylgalactosaminyltransferase activity |
| 03/22/2000 | EP0598129B1 Novel tetrapeptide derivative |
| 03/22/2000 | CN1247984A Diagnostic marking for human diseases |
| 03/21/2000 | US6040435 Antimicrobial cationic peptides |
| 03/21/2000 | US6040423 Solid phase synthesis using one-piece support to synthesize a plurality of different peptides by spotting n-protected amino acid solution in discrete zones, coupling c-terminal to support, then coupling additional amino acids |
| 03/21/2000 | US6040291 Antimicrobial peptide |
| 03/21/2000 | US6040193 Combinatorial strategies for polymer synthesis |
| 03/21/2000 | US6040146 Detection of mammary tumor virus-like sequences in human breast cancer |
| 03/21/2000 | US6039947 Peptides and amino acid sequences for stimulating for treatment of multiple sclerosis |
| 03/21/2000 | CA2048655C Discrimination between antibodies against htlv-1, htlv-ii or related retroviruses, new peptides, detection of antibodies and immunoassay kits |
| 03/16/2000 | WO2000014542A2 Diagnostic method for detecting disturbances of the pancreas |
| 03/16/2000 | WO2000014536A1 Production of motif-specific and context-independent antibodies using peptide libraries as antigens |
| 03/16/2000 | WO2000014215A1 Method for selecting peptides for the targeted transport of drugs and markers, and peptides discovered using said method |
| 03/16/2000 | WO2000006694A3 Compound and method for the prevention and/or the treatment of allergy |